RxDoctor Payments Data

Virginia Oneil, PA

Physician Assistant · Norwood, MANPI 1669471041

Payments from drug & device makers

$3,767in general payments, 2019–2025

Across 155 payments — averaging $24.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$989
  • 180 Medical, Inc.$304
  • Tolmar, Inc.$183
  • Sumitomo Pharma America, Inc.$149
  • Urovant Sciences Inc$144
  • Johnson & Johnson$138
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$3,14884%
  • Education$61816%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,767 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$3,830
Medicare patients
56
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide11$151,583
GemtesaVibegron32$33,248
MyrbetriqMirabegron16$15,199
Tamsulosin Hcl289$5,601
Finasteride260$4,061
Methenamine Hippurate43$3,465
Oxybutynin Chloride ErOxybutynin Chloride71$2,830
Alfuzosin Hcl ErAlfuzosin Hcl82$2,123
Dutasteride39$1,809
Solifenacin Succinate24$1,805
Cefpodoxime Proxetil37$1,279
Cephalexin13$403
Ciprofloxacin Hcl31$136
Ampicillin Trihydrate13$135
Oxybutynin Chloride12$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$989$166,78127 claims
Sumitomo Pharma America, Inc.Gemtesa$149$33,24832 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Norwood

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →